Understanding of arthrofibrosis: New explorative insights into extracellular matrix remodeling of synovial fibroblasts
PLOS ONE · 26.05.2023 · 18 (5) · e0286334
DOI: 10.1371/journal.pone.0286334 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, online erschienen am 26.05.2023. Verfasst von Thanh-Diep Ly und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institut für Laboratoriums- und Transfusionsmedizin, Herz- und Diabeteszentrum NRW, Universitätsklinik der Ruhr-Universität Bochum, Bad Oeynhausen, N…. Hauptthemen laut MEDLINE: Atrial Fibrillation, Joint Diseases. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Arthrofibrosis following total knee arthroplasty is a fibroproliferative joint disorder marked by dysregulated biosynthesis of extracellular matrix proteins, such as collagens and proteoglycans. The underlying cellular events remain incompletely understood. Myofibroblasts are highly contractile matrix-producing cells characterized by increased alpha-smooth muscle actin expression and xylosyltransferase-I (XT-I) secretion. Human XT-I has been identified as a key mediator of arthrofibrotic remodeling. Primary fibroblasts from patients with arthrofibrosis provide a useful in vitro model to identify and characterize disease regulators and potential therapeutic targets. This study aims at characterizing primary synovial fibroblasts from arthrofibrotic tissues (AFib) regarding their molecular and cellular phenotype by utilizing myofibroblast cell culture models. Compared to synovial control fibroblasts (CF), AFib are marked by enhanced cell contractility and a higher XT secretion rate, demonstrating an increased fibroblast-to-myofibroblast transition rate during arthrofibrosis. Histochemical assays and quantitative gene expression analysis confirmed higher collagen and proteoglycan expression and accumulation in AFib compared to CF. Furthermore, fibrosis-based gene expression profiling identified novel modifier genes in the context of arthrofibrosis remodeling. In summary, this study revealed a unique profibrotic phenotype in AFib that resembles some traits of other fibroproliferative diseases and can be used for the future development of therapeutic interventions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institut für Laboratoriums- und Transfusionsmedizin, Herz- und Diabeteszentrum NRW, Universitätsklinik der Ruhr-Universität Bochum, Bad Oeynhausen, North Rhine-Westphalia, Germany.
- Orthopädische Beratung und Begutachtung, Bad Oeynhausen, North Rhine-Westphalia, Germany.
ORCID-Profile: Isabel Faust-Hinse
Zitieren
APA
Ly, T. D., Sambale, M., Klösener, L., Traut, P., Fischer, B., Hendig, D., Kuhn, J., Knabbe, C., & Faust-Hinse, I. (2023). Understanding of arthrofibrosis: New explorative insights into extracellular matrix remodeling of synovial fibroblasts. PLOS ONE, 18(5), e0286334. https://doi.org/10.1371/journal.pone.0286334
Vancouver
Ly TD, Sambale M, Klösener L, Traut P, Fischer B, Hendig D, et al. Understanding of arthrofibrosis: New explorative insights into extracellular matrix remodeling of synovial fibroblasts. PLOS ONE. 2023;18(5):e0286334. doi:10.1371/journal.pone.0286334
BibTeX
@article{Ly2023,
author = {Ly, Thanh-Diep and Sambale, Meike and Klösener, Lara and Traut, Philipp and Fischer, Bastian and Hendig, Doris and Kuhn, Joachim and Knabbe, Cornelius and Faust-Hinse, Isabel},
title = {Understanding of arthrofibrosis: New explorative insights into extracellular matrix remodeling of synovial fibroblasts},
journal = {PLOS ONE},
year = {2023},
volume = {18},
number = {5},
pages = {e0286334},
doi = {10.1371/journal.pone.0286334}
}
EUVIMED